is ghk-cu a peptide – Research GHK-CU (50mg) – Nordsci
Description
Proteolysis-targeting chimera (PROTAC): Current applications and future directions
Isabella et al., 2020)
This is a different satiety circuit than the hypothalamic pathway engaged by GLP-1 agonists
This may be more common in patients who: are under-eating recently lost significant weight have poor protein intake are combining multiple wellness therapies simultaneously Injection Site Reactions Because many peptide therapies are injectable, patients may occasionally notice: redness swelling itching bruising tenderness Injection technique and sterile handling matter significantly
